Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

Open Access Research

SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice

Jin-Hong Shin1, Brian Bostick1, Yongping Yue1, Roger Hajjar2 and Dongsheng Duan1*

Author Affiliations

1 Department of Molecular Microbiology and Immunology, School of Medicine, The University of Missouri, Columbia, MO, USA

2 Department of Cardiology, Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY, USA

For all author emails, please log on.

Journal of Translational Medicine 2011, 9:132  doi:10.1186/1479-5876-9-132

Published: 11 August 2011

Abstract

Background

Cardiomyocyte calcium overloading has been implicated in the pathogenesis of Duchenne muscular dystrophy (DMD) heart disease. The cardiac isoform of sarcoplasmic reticulum calcium ATPase (SERCA2a) plays a major role in removing cytosolic calcium during heart muscle relaxation. Here, we tested the hypothesis that SERCA2a over-expression may mitigate electrocardiography (ECG) abnormalities in old female mdx mice, a murine model of DMD cardiomyopathy.

Methods

1 × 1012 viral genome particles/mouse of adeno-associated virus serotype-9 (AAV-9) SERCA2a vector was delivered to 12-m-old female mdx mice (N = 5) via a single bolus tail vein injection. AAV transduction and the ECG profile were examined eight months later.

Results

The vector genome was detected in the hearts of all AAV-injected mdx mice. Immunofluorescence staining and western blot confirmed SERCA2a over-expression in the mdx heart. Untreated mdx mice showed characteristic tachycardia, PR interval reduction and QT interval prolongation. AAV-9 SERCA2a treatment corrected these ECG abnormalities.

Conclusions

Our results suggest that AAV SERCA2a therapy may hold great promise in treating dystrophin-deficient heart disease.